3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
52
Ovarian Neoplasms
40
Multiple Myeloma
20
Fallopian Tube Neoplasms
13
Lymphoma
12
Sarcoma
11
Carcinoma, Ovarian Epithelial
11
Triple Negative Breast Neoplasms
8
Recurrence
8
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Hodgkin Disease
6
Neoplasms, Plasma Cell
5
Sarcoma, Ewing
4
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Mantle-Cell
4
Burkitt Lymphoma
4
Rhabdomyosarcoma
3
Osteosarcoma
3
Lymphoma, T-Cell, Peripheral
3
Leiomyosarcoma
3
Breast Neoplasms, Male
3
Uterine Cervical Neoplasms
2
Solid Tumors
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Interventions
Cyclophosphamide
65
Rituximab
62
fludarabine
40
Etoposide
25
Lenalidomide
19
fludarabine phosphate
17
Immunotherapy, Adoptive
17
Doxorubicin
17
Cytarabine
17
Vincristine
15
Magnetic Resonance Spectroscopy
14
Prednisone
13
pembrolizumab
11
Specimen Handling
11
Dexamethasone
10
CT-P10
10
Melphalan
9
Carmustine
9
Carboplatin
9
Bortezomib
9
Bendamustine Hydrochloride
9
obinutuzumab
8
ibrutinib
8
Mycophenolic Acid
8
Biopsy
8
Radiotherapy
7
Ifosfamide
7
polatuzumab vedotin
6
Whole-Body Irradiation
6
Methotrexate
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, B-Cell
×
liposomal doxorubicin
×
Clear all
NCT05270057
2025-10-09
LONCA
Medical College of Wisconsin
Phase 1
Active not recruiting
11 enrolled